StockData
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) stock

JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30122% above fair value
$240.71+0.94 (+0.39%)

Close on Nov 17, 2026Market cap $15.63BP/E 78.4Yield –

Jazz Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Jazz Pharmaceuticals's market cap was $16.01B on Nov 11, 2026, against $10.83B a year earlier. Over the last 5 years it ranged from $6.77B to $16.17B, with a median of $8.58B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.01B+53.6%
2025Dec 31, 2025$10.43B+27.8%
2024Dec 31, 2024$8.16B-4.8%
2023Dec 29, 2023$8.57B-14.2%
2022Dec 30, 2022$9.98B+32.6%
2021Dec 31, 2021$7.53B-19.0%
2020Dec 31, 2020$9.30B+6.8%
2019Dec 31, 2019$8.71B+14.4%
2018Dec 31, 2018$7.61B-7.7%
2017Dec 29, 2017$8.25B+21.4%
2016Dec 30, 2016$6.80B-26.0%
2015Dec 31, 2015$9.18B-8.5%
2014Dec 31, 2014$10.04B+29.1%
2013Dec 31, 2013$7.78B+157.4%
2012Dec 31, 2012$3.02B+71.5%
2011Dec 30, 2011$1.76B+198.3%
2010Dec 31, 2010$590.75M–

More Jazz Pharmaceuticals figures

See a number that looks wrong?